Andra AP fonden Has $32.52 Million Position in Intuitive Surgical, Inc. $ISRG

Andra AP fonden boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 63.4% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 81,770 shares of the medical equipment provider’s stock after purchasing an additional 31,720 shares during the period. Andra AP fonden’s holdings in Intuitive Surgical were worth $32,518,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in ISRG. Norges Bank purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $2,856,987,000. Bank of New York Mellon Corp purchased a new stake in shares of Intuitive Surgical during the second quarter worth $1,335,753,000. J. Stern & Co. LLP raised its holdings in shares of Intuitive Surgical by 18,504.6% during the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after acquiring an additional 2,115,814 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Polen Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at $477,225,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock worth $4,891,989 in the last ninety days. 0.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ISRG shares. Robert W. Baird dropped their target price on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Citigroup lowered their price target on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research note on Friday, July 17th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. JPMorgan Chase & Co. cut their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research report on Friday, July 17th. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a research note on Monday, July 6th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $508.68.

Intuitive Surgical Price Performance

ISRG traded down $0.17 on Tuesday, hitting $401.48. The company had a trading volume of 615,827 shares, compared to its average volume of 2,450,544. The company’s fifty day moving average price is $372.58 and its 200 day moving average price is $418.49. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a market cap of $141.84 billion, a price-to-earnings ratio of 46.01, a price-to-earnings-growth ratio of 2.97 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter last year, the company posted $1.81 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.